Brachial plexus block with ropivacaine and bupivacaine for the formation of arteriovenous fistula in patients with end-stage renal failure [2]

European Journal of Anaesthesiology

Volumn 22, Issue 6, 2005, Pages 473-475

  Misiolek, H D ^a,b   Kucia, H J ^b   Knapik, P ^b   Werszner, M M ^b   Karpe, J W ^b   Gumprecht, J ^b  

^a SP Szpital Kliniczny Nt 1 ^*  (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; ROPIVACAINE;

ADULT; AGED; ANESTHETIC RECOVERY; ARTERIOVENOUS FISTULA; BRACHIAL PLEXUS ANESTHESIA; BREATHING RATE; CARDIOTOXICITY; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LETTER; LUNG HEMODYNAMICS; MALE; NEUROTOXICITY; OXYGEN SATURATION; SYSTOLIC BLOOD PRESSURE; VASCULAR ACCESS;

AGED; AMIDES; ANESTHETICS, LOCAL; BRACHIAL PLEXUS; BUPIVACAINE; CATHETERS, INDWELLING; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NERVE BLOCK; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 20844449067     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021505220811     Document Type: Letter

References (6)

1. Rodriguez J, Quintela O, Lopez-Rivadula M, Barcena M, Diz C, Alvarez J. High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study. Eur J Anesthesiol 2001; 18: 171-176.
2. McClellan KJ, Faulds D. Ropivacaine: an update of its use in regional anaesthesia. Drugs 2000; 60: 1065-1093.
3. Klein SM, Greengrass RA, Steele SM, et al. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block. Anesth Analg 1998; 87: 1316-1391.
4. McGlade DP, Kalpokas MV, Mooney PH. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care 1998; 26: 515-520.
5. Raeder JC, Drosdahl S, Klaastad O, et al. Axillary brachial plexus block with ropivacaine 7.5 mg/ml. A comparative study with bupivacaine 5 mg/ml. Acta Anesthesiol Scand 1999; 43: 794-798.
6. Pere P, Salonen M, Jokinen M, Rosenberg PH, Neuvonen PJ, Haasio J. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block. Anesth Analg 2003; 96: 563-569.